PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-06-18	0.2770 kr	-3.82%	84,633
26-06-17	0.2880 kr	0.00%	52,426
26-06-16	0.2880 kr	-3.36%	79,011
26-06-15	0.2980 kr	0.00%	31,892
26-06-12	0.2980 kr	+0.68%	103,775

End-of-day quote SPOTLIGHT STOCK MARKET AB

More quotes

Income Statement and Estimates

More financial data

End-of-day quote SPOTLIGHT STOCK MARKET AB Other stock markets 2026-06-18			5-day change	1st Jan Change
0.2770 ^SEK	-3.82%		-7.05%	+27.06%

06-10	Pexa secures order from the US	FW
06-02	Doctoral thesis presents findings from studies using Pexa technology	FW

Market Cap	34.39M 3.59M 3.13M 2.9M 2.71M 5.09M 339M 5.12M 13.33M 167M 13.47M 13.18M 579M	P/E 2024	-1.13x	P/E 2025	-2.73x
Enterprise Value	28.15M 2.94M 2.56M 2.37M 2.22M 4.17M 277M 4.19M 10.91M 136M 11.03M 10.79M 474M	EV / Sales 2024	8.49x	EV / Sales 2025	6.47x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

06-10	Pexa secures order from the US	FW
06-02	Doctoral thesis presents findings from studies using Pexa technology	FW
05-22	PExA AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-22	Pexa reports revenue growth in Q1 as bottom line improves	FW
05-13	Pexa joins Dutch research project for lung diseases as industrial partner	FW
05-06	PExA AB Auditor Raises 'Going Concern' Doubt	CI
05-04	Pexa secures order from German BAuA	FW
04-20	Additional funding for Örebro University strengthens Pexa's role in research environment	FW
03-05	Pexa Secures Norwegian Order for Research Instrument in Occupational Health Study	FW
03-04	Pexa Aims to Become a Tool for Early Detection of Lung Cancer - CEO	FW
02-19	Pexa Reports Decreased Revenue in Q4	FW
02-19	PExA AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-14	Pexa Granted a U.S. Patent	FW

11-07	Pexa - Q3 Presentation 2025	FW
11-07	Pexa Reports Minor Earnings Changes as Company Advances Toward Diagnostic Applications	FW

PExA AB Stock

Stocks

PEXA B

SE0007412374

Advanced Medical Equipment & Technology

Valuation: PExA AB

Chart: PExA AB

Latest news : PExA AB

Analysts' recommendations: PExA AB

Press Releases: PExA AB

Quotes and Performance

Course Extremes

Managers and Directors: PExA AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

06-10	PExA : U.S. government agency customer orders upgrade of existing PExA system	PU
06-02	PExA : New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases	PU
05-13	PExA : partner in Dutch precision medicine project within COPD and interstitial lung diseases	PU
05-04	PExA : receives order from German Federal Institute BAuA for second instrument	PU
04-20	PExA : Additional funding strengthens a growing research environment in Örebro where PExA is used in multiple studies	PU

1 day	-3.82%
1 week	-7.05%
Current month	+10.80%
1 month	+27.06%
3 months	+15.42%
6 months	+20.43%
Current year	+27.06%

1 week	0.27	0.38
1 month	0.22	0.38
Current year	0.18	0.6
1 year	0.14	0.8
3 years	0.14	1.06
5 years	0.14	2.08
10 years	0.14	12.5

Manager	Title	Age	Since
Bengt Tomas Jan Gustafsson CEO	Chief Executive Officer	55	-
Jörgen Östling CTO	Chief Tech/Sci/R&D Officer	-	2017-12-31
Svante Höjer CTO	Chief Tech/Sci/R&D Officer	65	2014-12-31

Director	Title	Age	Since
Anna-Carin Olin BRD	Director/Board Member	66	2009-12-31
Claes Frederik Holmberg CHM	Chairman	72	2014-01-30
Björn Lennart Dahlöf BRD	Director/Board Member	73	2020-12-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PEXA AB	-3.82%	-7.05%	+18.38%	-53.37%	3.59M
SARTORIUS AG	-1.89%	-7.87%	-1.02%	-29.61%	15.63B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-2.00%	-5.63%	+28.64%	+51.43%	1.57B
ECKERT & ZIEGLER SE	+0.19%	+1.50%	-26.49%	+23.17%	1.12B
QUIDELORTHO CORPORATION	+4.11%	-3.26%	-51.75%	-84.40%	932M
CONTEC MEDICAL SYSTEMS CO.,LTD	+5.56%	+4.30%	-14.86%	-51.11%	677M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+0.58%	-2.73%	-40.15%	-58.91%	554M
VAREX IMAGING CORPORATION	+3.24%	-4.62%	+37.29%	-54.10%	444M
REVENIO GROUP OYJ	-1.26%	-0.32%	-54.06%	-62.18%	382M
CELLAVISION AB	-3.12%	-1.01%	-24.84%	-23.58%	341M
Average	+0.16%	-2.28%	-12.89%	-34.27%	2.17B
Weighted average by Cap.	-1.14%	-6.14%	-4.32%	-25.78%

	2024	2025
Net sales	720K 75.12K 65.5K 60.66K 56.79K 106K 7.09M 107K 279K 3.49M 282K 276K 12.11M	3.22M 336K 293K 271K 254K 477K 31.72M 480K 1.25M 15.61M 1.26M 1.23M 54.22M
Net income	-10.16M -1.06M -925K -857K -802K -1.5M -100M -1.51M -3.94M -49.27M -3.98M -3.9M -171M	-6.25M -652K -569K -527K -493K -925K -61.53M -930K -2.42M -30.29M -2.45M -2.4M -105M
Net Debt	-5.59M -584K -509K -471K -441K -828K -55.09M -833K -2.17M -27.12M -2.19M -2.14M -94.16M	-6.24M -651K -568K -526K -492K -924K -61.46M -929K -2.42M -30.25M -2.45M -2.39M -105M